Suprainguinal Fascia Iliaca (SIFI) Block Improves Analgesia Following Total Hip Arthroplasty
| Status: | Recruiting |
|---|---|
| Conditions: | Arthritis, Chronic Pain, Osteoarthritis (OA) |
| Therapuetic Areas: | Musculoskeletal, Rheumatology |
| Healthy: | No |
| Age Range: | 18 - 75 |
| Updated: | 2/9/2019 |
| Start Date: | August 1, 2017 |
| End Date: | January 2, 2020 |
| Contact: | William M Bullock, MD, PhD |
| Email: | william.bullock@duke.edu |
| Phone: | 919-668-2024 |
The purpose of this study is to learn if using a suprainguinal fascia iliaca (SIFI) injection
technique (also called a "nerve block") that numbs the nerves going to the side and front of
the upper leg will improve pain control after surgery. The SIFI technique uses a numbing
solution (local anesthetics) that is injected next to nerves in the hip to reduce pain. This
block may affect movement in the leg and make the legs weak. The amount of leg weakness is
not known and assessment of this will be included in the study. Many institutions use the
SIFI block for patients having total hip replacements, with the hope of providing good pain
relief combined with improved mobility after surgery.
technique (also called a "nerve block") that numbs the nerves going to the side and front of
the upper leg will improve pain control after surgery. The SIFI technique uses a numbing
solution (local anesthetics) that is injected next to nerves in the hip to reduce pain. This
block may affect movement in the leg and make the legs weak. The amount of leg weakness is
not known and assessment of this will be included in the study. Many institutions use the
SIFI block for patients having total hip replacements, with the hope of providing good pain
relief combined with improved mobility after surgery.
Inclusion Criteria:
- English speaking
- between 18 and 75 years old
- American Society of Anesthesiologists (ASA) 1-3 patients undergoing primary total hip
arthroplasty
Exclusion Criteria:
- ASA 4 or 5
- revision hip arthroplasty
- diagnosis of chronic pain
- daily chronic opioid use (over 3 months of continuous opioid use)
- inability to communicate pain scores or need for analgesia
- acute hip fracture
- Infection at the site of block placement
- Age under 18 years old or greater than 75 years old
- Pregnant women
- Intolerance/allergy to local anesthetics
- Weight <50 kg
- Suspected, or known addiction to or abuse of illicit drug(s), prescription
medicine(s), or alcohol within the past 2 years.
- Uncontrolled anxiety, schizophrenia, or other psychiatric disorder that, in the
opinion of the investigator, may interfere with study assessments or compliance
- Current or historical evidence of any clinically significant disease or condition
that, in the opinion of the investigator, may increase the risk of surgery or
complicate the subject's postoperative course.
We found this trial at
1
site
Durham, North Carolina 27705
Principal Investigator: William M Bullock, MD, PhD
Phone: 505-715-7000
Click here to add this to my saved trials
